Evotec and Bristol Myers Squibb enter licence agreement within neuroscience partnership

FHS
July 13, 2023
1:13 pm

Evotec SE today announced that Bristol Myers Squibb Company has exercised its option to enter into an exclusive global licence agreement.

Canadian guideline expands treatment options for opioid use disorder

An updated evidence-based guideline aimed at helping clinicians and other health care providers manage patients with opioid use disorder recommends buprenorphine and methadone as first-line

November 12, 2024

Psychedelic Investor Survey Q3 2024 – Psychedelic Alpha

Now, let’s disaggregate those sentiment scores by investor type. More institutional-type investors, in red, have become more bullish since our last survey, with nearly half

November 19, 2024

South Korean pricing reform suggests more flexible drug reimbursement negotiations – Pharmaceutical Technology

South Korea’s Ministry of Health and Welfare (MoHW) recently disclosed its proposal to revise the drug reimbursement and price-setting regulations as a part of the

October 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.